<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-C0OXOO0A</identifier><date>2007</date><creator>Čufer, Tanja</creator><creator>Matos, Erika</creator><relation>documents/doc/C/URN_NBN_SI_doc-C0OXOO0A_001.pdf</relation><relation>documents/doc/C/URN_NBN_SI_doc-C0OXOO0A_001.txt</relation><format format_type="issue">3</format><format format_type="volume">41</format><format format_type="type">article</format><format format_type="extent">str. 115-122</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">23500761</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-C0OXOO0A</identifier><language>eng</language><publisher publisher_location="[Zagreb]">Croatian Medical Association - Croatian Society of Radiology</publisher><publisher publisher_location="Ljubljana">Slovenian Medical Society - Section of Radiology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>InC</rights><subject language_type_id="slv">Antagonists And Inhibitors</subject><subject language_type_id="slv">Antibodies, Monoclonal</subject><subject language_type_id="slv">Breast Neoplasms</subject><subject language_type_id="slv">Dojka, novotvorbe</subject><subject language_type_id="slv">dojke</subject><subject language_type_id="slv">Drug Therapy</subject><subject language_type_id="slv">novotvorbe</subject><subject language_type_id="slv">Protitelesa monoklonska</subject><subject language_type_id="slv">Proto-Oncogene Proteins C-Erbb-2</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="slv">zdravljenje</subject><title>Adjuvant treatment of breast cancer patients with trastuzumab</title></Record>